Amedisys
AMED
AMED was delisted on the 14th of August, 2025.
166 hedge funds and large institutions have $1.19B invested in Amedisys in 2015 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 63 increasing their positions, 54 reducing their positions, and 24 closing their positions.
484% more call options, than puts
Call options by funds: $7.48M | Put options by funds: $1.28M
17% more repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 54
3% more capital invested
Capital invested by funds: $1.15B → $1.19B (+$37.4M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
5% less funds holding
Funds holding: 174 → 166 (-8)
21% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 24
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$18.5M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$17.1M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$11.6M |
| 4 |
RCAMU
Rothschild & Co Asset Management US
Stamford,
Connecticut
|
+$10.6M |
| 5 |
SFM
Systematic Financial Management
Teaneck,
New Jersey
|
+$8.68M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NTC
North Tide Capital
Boston,
Massachusetts
|
-$80M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$9.77M |
| 3 |
Millennium Management
New York
|
-$6.76M |
| 4 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$5M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$3.55M |
AMED Hedge Fund Activity: Q4 2015 in Review
166 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q4 2015, worth a combined $1.19B — up 3.3% from $1.15B a quarter earlier.
Sellers outnumbered buyers: 24 funds closed out of AMED and 19 opened new positions — a net loss of 5 holders — while 54 trimmed existing stakes and 63 added.
The largest buyer was Fidelity Investments, adding an estimated $18.5M. The largest seller was North Tide Capital, cutting an estimated $80M.
- 166 institutional investors held Amedisys (AMED) as of Q4 2015, down from 174 in Q3 2015.
- Funds reported $1.19B of Amedisys stock for Q4 2015, up 3.3% quarter-over-quarter.
- 19 funds opened new Amedisys positions in Q4 2015 and 24 closed out, a net change of -5 holders.
- The largest Amedisys buyer in Q4 2015 was Fidelity Investments, an estimated $18.5M added.
- The largest Amedisys seller in Q4 2015 was North Tide Capital, an estimated $80M sold.
Based on aggregated 13F filings for Q4 2015.